Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

Understanding the Complexities of The Tepezza Multi-District Litigation Lawsuit

As the legal industry constantly evolves, it encounters multifaceted cases involving innovative technologies or, as frequently, novel medical treatments. A salient example of this is the ongoing multi-district litigation (MDL) concerning Tepezza (teprotumumab-trbw) – a groundbreaking medication developed by Horizon Therapeutics for the treatment of Thyroid Eye Disease. [1]

Horizon Therapeutics came under legal fire for its choice to suspend Tepezza distribution to new patients. The company attributed the decision to Operation Warp Speed (the U.S. Federal Government’s COVID-19 vaccine manufacturing and distribution endeavor), which had prioritized the manufacturing of COVID-19 vaccines in Pfizer’s manufacturing facility. The facility was a crucial part of the Tepezza production line. [2]

However, the fallout from this decision has been the subject of several lawsuits, leading to complex, multi-district litigation that bears exploration.

Understanding Multi-District Litigation 

Before delving into the intricacies of the Tepezza litigation, it’s crucial to understand what makes multi-district litigation (MDL) distinct. Essentially, MDL is a process that consolidates multiple civil cases from different districts into one court. Judge Matthew Kennelly ruled on this centralized litigation concerning Tepezza in the Northern District of Illinois. [3]

The Root of the Lawsuit

The parties suing Horizon Therapeutics argue that the company misled investors regarding Tepezza. They claim Horizon failed to disclose that it would, in fact, be able to continue producing Tepezza despite Pfizer repurposing its facility for COVID vaccine manufacture. They argue Horizon misrepresented the situation to manipulate its stock prices. [3]:

The Lawsuit’s Implications

The future implications of this lawsuit depend on its outcome. If it goes in favor of the plaintiffs, it could set a precedent for other pharmaceutical companies about the level of transparency required when disclosing information that can affect stock prices. Moreover, it would pave an avenue for compensation to those affected.

If Horizon wins, it may send a message that these companies have considerable discretion in decision-making and communication. However, such an outcome could also lead to public and legal pressure for more stringent regulations on pharmaceutical industry disclosures.

Conclusion 

The case of the Tepezza MDL illustrates the complexity that can arise when the medical and legal fields intersect, particularly in an era impacted by a global pandemic. This case underscores the importance of proper investment information disclosure by pharmaceutical companies and the potential legal repercussions when this standard is not met. 

If you or a loved one has been injured by Tepezza, give us a call at the Michael Brady Lynch Firm at 888-585-5970. 

Date: June 30, 2023

Author: Brandon Salter and Anoop Desai

Citations

[1] https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-thyroid-eye-disease

[2] https://ir.horizontherapeutics.com/news-releases/news-release-details/horizon-therapeutics-plc-announces-fda-approval-update#:~:text=14%2C%202023%2D%2D%20Horizon%20Therapeutics,Eye%20Disease%20activity%20or%20duration.%E2%80%9D

[3] https://www.jpml.uscourts.gov/sites/jpml/files/MDL-3079-Transfer_Order-5-23.pdf

Suboxone Lawsuits: From Opioid Addiction Cure to MDL Defendant

Suboxone Lawsuits: From Opioid Addiction Cure to MDL Defendant

According to the National Center for Biotechnology Medicine, more people die from drug overdoses in the US than any other form of accidental death. Opioid overdoses outnumber the historical peak death rate of HIV, gun violence, and car crashes. There’s no doubt we’re in the middle of an opioid crisis. Often, people become addicted to this drug after a legitimate prescription to manage pain after surgery or a chronic pain condition.

read more
Video Game Lawsuits: Developers Face Legal Action for Addictive Gameplay

Video Game Lawsuits: Developers Face Legal Action for Addictive Gameplay

Over the past 20 to 30 years, studies and mainstream media outlets have blamed video games for desensitizing minors to violence, increased obesity rates, sedentary lifestyles, and mental health issues like depression and anxiety. Now, developers are facing video game lawsuits from gamers who have become addicted to video games. Learn more about video game addiction and what to do if you or a loved one have suffered from video game addiction below.

read more
Ozempic Lawsuit 2024: The Latest Updates

Ozempic Lawsuit 2024: The Latest Updates

The FDA has approved Ozempic, a medication manufactured by Dutch company Novo Nordisk, for treating type 2 diabetes. Many healthcare providers also prescribe Ozempic to their patients for weight management purposes. This is because the medication’s active ingredient, semaglutide, has been approved for weight loss treatments.

read more
PFAS Lawsuit Update: March 2024

PFAS Lawsuit Update: March 2024

Suboxone, a medication approved by the FDA for the treatment of opioid addiction, has garnered significant attention not just within medical circles but also in legal domains. Composed of buprenorphine and naloxone, Suboxone has been lauded for its effectiveness in reducing opioid withdrawal symptoms and cravings. However, its rise in use has been shadowed by a growing concern over its potential for abuse, dependency, and the risk of serious side effects.

read more
Cruise Ship Sexual Assault Prevention

Cruise Ship Sexual Assault Prevention

The cruising industry is booming, with new cruise ships being built and sailing away from Florida ports each year. While cruising is a relatively safe vacation, unfortunately, things don’t always go as planned. Crimes happen on cruise ships, just as they do anywhere else. Sexual assault is the most common crime reported on cruise ships. In 2023, there were 131 reports of sexual assault and rape on cruise ships.

read more
The Dangers of Suboxone and Emerging Lawsuits

The Dangers of Suboxone and Emerging Lawsuits

Suboxone, a medication approved by the FDA for the treatment of opioid addiction, has garnered significant attention not just within medical circles but also in legal domains. Composed of buprenorphine and naloxone, Suboxone has been lauded for its effectiveness in reducing opioid withdrawal symptoms and cravings. However, its rise in use has been shadowed by a growing concern over its potential for abuse, dependency, and the risk of serious side effects.

read more
Cruise Ship Sex Assaults

Cruise Ship Sex Assaults

Sexual abuse and assault aboard cruise ships is a pressing issue that continues to plague the cruise industry, raising concerns about the safety and security of passengers and crew members on these vessels. Despite many viewing cruises as idyllic getaways, the unfortunate reality is that incidents of sexual violence can and do happen, often with complications due to the international waters and jurisdictions in which these ships operate.

read more
Mental Health Concerns Prompt Social Media Lawsuits

Mental Health Concerns Prompt Social Media Lawsuits

Reports indicate that 90% of teens ages 13 to 17 are active on social media and spend upwards of nine hours on the internet a day. Although modern technology has many benefits to offer our society, research indicates that excessive social media use negatively affects the mental health of teenagers and young adults

read more
The Talcum Powder Lawsuit – A Legal Overview

The Talcum Powder Lawsuit – A Legal Overview

In recent years, a significant number of lawsuits have been filed against companies manufacturing talcum powder-based products, alleging that long-term use has led to health complications, particularly ovarian cancer and mesothelioma.

read more
×
What Our Clients Are Saying